miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells

被引:116
|
作者
Huang, Shuak [1 ]
Guo, Wei [1 ]
Tang, Yubo [1 ]
Ren, Dong [1 ]
Zou, Xuenong [1 ]
Peng, Xinsheng [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Orthopaed Res Inst, Guangzhou 510080, Guangdong, Peoples R China
关键词
prostate cancer cells; microRNAs; cancer stem cell; stemness; bone metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; SHORT BRANCH PEI; METASTASIS; MICRORNA; CARCINOMA; CD44; DIFFERENTIATION; PATTERNS; INVASION;
D O I
10.3892/or.2012.2015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence demonstrates that cancer stem cells (CSCs) are the critical drivers of tumor progression and metastasis. The inicroRNAs (miRNAs) may play a crucial role in repressing/promoting metastasis of cancer by regulating CSCs. A previous study showed that miR-143 and miR-145 play an important role in regulating bone metastasis of prostate cancer (PCa), but the exact mechanism of regulation of bone metastasis of PCa is not fully understood. In this study, we found that overexpression of miR-143 and miR-145 inhibited the cell viability and colony formation of PC-3 cells from PCa bone metastasis. Furthermore, miR-143 and miR-145 suppressed tumor sphere formation and expression of CSC markers and 'stemness' factors including CD133, CD44, Oct4, c-Myc and Klf4 in PC-3 cells. The study further found that miR-143 and miR-145 inhibit bone invasion and tumorigenicity of PC-3 cells in vivo. Collectively, these findings demonstrate that miR-143 and miR-145 inhibit CSC properties of PC-3 cells and suggest that miR-143 and miR-145 may play a significant role in the bone metastasis progression of PCa by regulating CSC characteristics.
引用
收藏
页码:1831 / 1837
页数:7
相关论文
共 50 条
  • [31] Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia
    Liu, Kejian
    Xuekelati, Saiyare
    Zhang, Yue
    Yin, Yin
    Li, Yue
    Chai, Rui
    Li, Xinwei
    Peng, Yi
    Wu, Jiangdong
    Guo, Xiaomei
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [32] Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia
    Kejian Liu
    Saiyare Xuekelati
    Yue Zhang
    Yin Yin
    Yue Li
    Rui Chai
    Xinwei Li
    Yi Peng
    Jiangdong Wu
    Xiaomei Guo
    BMC Cardiovascular Disorders, 17
  • [33] Characterization of miR-141 and miR-145 expression in cancer stem cells of metastatic prostate cancer patients
    Shukla, Kamla Kant
    Choudhary, Gautam Ram
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (11)
  • [34] Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
    A Pagliuca
    C Valvo
    E Fabrizi
    S di Martino
    M Biffoni
    D Runci
    S Forte
    R De Maria
    L Ricci-Vitiani
    Oncogene, 2013, 32 : 4806 - 4813
  • [35] A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
    Kaja Skjefstad
    Charles Johannessen
    Thea Grindstad
    Thomas Kilvaer
    Erna-Elise Paulsen
    Mona Pedersen
    Tom Donnem
    Sigve Andersen
    Roy Bremnes
    Elin Richardsen
    Samer Al-Saad
    Lill-Tove Busund
    Scientific Reports, 8
  • [36] Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression
    Pagliuca, A.
    Valvo, C.
    Fabrizi, E.
    di Martino, S.
    Biffoni, M.
    Runci, D.
    Forte, S.
    De Maria, R.
    Ricci-Vitiani, L.
    ONCOGENE, 2013, 32 (40) : 4806 - 4813
  • [37] A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
    Skjefstad, Kaja
    Johannessen, Charles
    Grindstad, Thea
    Kilvaer, Thomas
    Paulsen, Erna-Elise
    Pedersen, Mona
    Donnem, Tom
    Andersen, Sigve
    Bremnes, Roy
    Richardsen, Elin
    Al-Saad, Samer
    Busund, Lill-Tove
    SCIENTIFIC REPORTS, 2018, 8
  • [38] Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment
    Avgeris, Margaritis
    Mavridis, Konstantinos
    Tokas, Theodoros
    Stravodimos, Konstantinos
    Fragoulis, Emmanuel G.
    Scorilas, Andreas
    CARCINOGENESIS, 2015, 36 (05) : 528 - 537
  • [39] miR-143和miR-145在胃癌中的表达及功能研究
    邢晓芳
    李子禹
    中华胃肠外科杂志, 2015, (01) : 50 - 53
  • [40] miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells
    Gomes, Sofia E.
    Simoes, Andre E. S.
    Pereira, Diane M.
    Castro, Rui E.
    Rodrigues, Cecilia M. P.
    Borralho, Pedro M.
    ONCOTARGET, 2016, 7 (08) : 9369 - 9388